Renji hospital affiliated to Shanghai jiaotong Uni school of medicine
Shanghai, China
Location status: Recruiting
Location contact
study director
CONTACT
NCT Number: NCT06968221
The primary purpose of this prospective, randomized multicenter center study is to evaluate and compare the outcomes of stomach,colorectal and lung anastomoses reinforced with a bioabsorbable staple line reinforcement material compared with standard non-reinforced techniques with respect to the incidence of postoperative hemorrage rate, anastomotic leakage, if applicable.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Phase 3
Shanghai, China
Location status: Recruiting
study director
CONTACT
This is a randomized prospective trial that compares the use of Cingular Bioabsorbable Staple Line Reinforcement to standard stapling techniques in tissue resections. The potential exists to utilize staple line reinforcement as a means of lowering the rate of post-operative hemorrage rate, anastomotic leakage.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
cingular Bioabsorbable Staple Line Reinforcement
Time frame: 10 min
The primary endpoint for the study is the proportion of subjects who experience a hemorrage through 10 min post procedure.
Time frame: 1-3 months
The primary endpoint for the study is the proportion of subjects who experience a clinical and/or radiologic anastomotic leak through 1-3 months post procedure.
Contact information is provided by the study sponsor or research team.
Shanghai Cingularbio Co. Ltd
Industry
A Study on the Safety and Efficacy of Using Cingular Bovine Pericardium Anastomosis Reinforcement Membrane for Tissue Reinforcement and Hemostasis at Anastomotic Sites
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03602079
Adenocarcinoma, Adnexal Diseases
Sarasota, Florida, United States
View Trial DetailsNCT06802172
Behavior, Breast Cancer Stage I
Anchorage, Alaska, United States
View Trial DetailsNCT07176182
Colorectal Neoplasms, Digestive System Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT06565052
Colonic Diseases, Colorectal Cancer
Boston, Massachusetts, United States
View Trial Details